Advocacy
The ALS Association filed a formal objection to health insurer CIGNA for the company’s decision to exclude Relyvrio from its formulary as part of our continued fight to ensure access…
The ALS Association is launching an ambitious slate of federal and state policy priorities for 2023. The priorities build upon the successes achieved and focus on augmenting our work to…
For the second year in a row, Bitcoin enthusiasts, athletes of all abilities, and supporters of the ALS/MND community around the world joined forces with the Golden West Chapter of…
The ALS Association recently sent letters to 43 of the largest insurance companies and health care payers to make RELYVRIO, which was formerly developed as AMX0035 and approved by the…
Submit you comment HERE. Seat elevation systems in power wheelchairs help people living with ALS, but Medicare does not cover these important mobility devices. After three years of requests from The…
It’s that time of year again when millions of Americans across the nation are making their plans to travel to be with family and friends to celebrate the holidays. While…